Thiotepa-based Conditioning Pre-Allo SCT

Phase 1 Trial of Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

More Information

Trial Status
Not yet accepting
Trial Phase
Phase 1
Enrollment
48 patients (estimated)
Tags
Alkylating Agent, Allogeneic Stem Cell Transplant, Pre-Allogeneic Stem Cell Transplant
Trial Type
Treatment
Last Update
SparkCures ID
2252
NCT Identifier
NCT07565220

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.